17/06/2026
Where is biotech heading - and what does that mean for founders building in it today?
Shahar Tzafrir joined leading life sciences investors at Biomed 2026 last week - covering everything from what gets a company funded to the myths Israeli founders still believe, and where the sector is heading as AI reshapes the economics of drug and device development.
Full coverage in גלובס - Globes (Hebrew):